Stand behind Ukrainian independent journalism when it’s needed most. Help us reach 20,000 members.

Skip to content
Edit post

Ukraine to purchase Molnupiravir pills to treat Covid-19

by Victoria Petryk December 19, 2021 1:11 PM 1 min read
Ukraine to buy 300,000 courses of Molnupiravir, an antiviral Covid-19 treatment pill by pharmaceutical company Merck. (Merck & Co)
This audio is created with AI assistance

The Health Ministry has signed an agreement to purchase Molnupiravir for the treatment of Covid-19, Deputy Health Minister Oleksandr Komarida announced on Dec. 17. Ukraine will purchase 300,000 courses of experimental antiviral pills.

“Molnupiravir is a medication that blocks an enzyme needed by the virus to reproduce the genetic code. This should prevent the virus from multiplying and reduce the risk of severe disease,” said Komarida. "The drug is a pill, so it has no special storage requirements and is convenient to take.”

Molnupiravir was developed by the science and technology company Merck & Co. in collaboration with Ridgeback Biotherapeutics.

According to the company's latest news release, early treatment with Molnupiravir significantly reduced the risk of hospitalization or death in at-risk, unvaccinated adults with Covid-19. More recent preclinical evidence indicates that Molnupiravir has antiviral activity against Omicron, a new fast-spreading Covid-19 strain that has just been detected in Ukraine.

On Dec. 16, Ukraine signed a contract to buy 300,000 courses of another experimental antiviral Covid-19 treatment pill, Paxlovid, developed by Pfizer. It reduces the level of hospitalization or death for adults at risk suffering from Covid-19 by 89% and is effective against the Omicron strain.

On Nov. 19, European Medicines Agency (EMA) issued advice on the use of Molnupiravir for the treatment of Covid-19 in those who have at least one risk factor for developing severe illness. EMA suggests Molnupiravir pills be taken as soon as Covid-19 is detected and within five days of the start of symptoms, twice a day.

The UK was the first to authorize Molnupiravir Covid-19 pills, Reuters reported.

Independent journalism needs a community —
not a paywall.

We’re working hard to show the world the truth of Russia’s brutal war — and we’re keeping it free for everyone, because reliable information should be available to all.

Our goal: reach 20,000 members to prove independent journalism can survive without paywalls, billionaires, or compromise. Will you help us do it?

Can we reach 20,000 members?

News Feed

11:51 PM

Trump 'very surprised, disappointed' at Russian attacks on Ukraine amid peace talks.

"I've gotten to see things I was very surprised at. Rockets being shot into cities like Kyiv during a negotiation that was maybe very close to ending," Trump said during a news conference in the Oval Office. "All of a sudden rockets got shot into a couple of cities and people died. I saw thing I was surprised at and I don't like being surprised, so I'm very disappointed in that way."
5:10 PM

All territory will revert to Ukraine, predicts US diplomat.

The Kyiv Independent’s Chris York sits down with Michael Carpenter, former U.S. Ambassador to OSCE and senior director for Europe at the National Security Council, to discuss the current lagging U.S. military support for Ukraine amid the ongoing ceasefire talks with Russia. Carpenter also offers his predictions for the future of Ukraine’s occupied territories.
MORE NEWS

Editors' Picks

Enter your email to subscribe
Please, enter correct email address
Subscribe
* indicates required
* indicates required
Subscribe
* indicates required
* indicates required
Subscribe
* indicates required
Subscribe
* indicates required
Subscribe
* indicates required

Subscribe

* indicates required
Subscribe
* indicates required
Subscribe
* indicates required
Explaining Ukraine with Kate Tsurkan
* indicates required
Successfuly subscribed
Thank you for signing up for this newsletter. We’ve sent you a confirmation email.